| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.022 | 0.9 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.0039 | 1 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |